The performance of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the patent expiration in key regions has introduced significant uncertainty . Investors are now assessing the impact of generic co